Encequidar

gut-restrict. P-gp inh. for oral paclitaxel combo

efficacious in Ph. III, NDA filed but CRL issued

from opt. of tariquidar

J. Med. Chem., Mar. 17, 2021

Athenex / Hanmi Pharmaceutical, Seoul, KR

The Athenex/Hanmi Pharmaceutical P‑gp transporter inhibitor (encequidar) is a gut-restricted compound intended to reduce efflux and increase absorption of the IV drug, paclitaxel to enable oral paclitaxel delivery.  The…


 this content is exclusive to
Premium members

Unlock this content with a Premium membership to read it now.